At a glance
- Originator Meiji Seika Kaisha
- Developer Meiji Seika Pharma
- Class Hepatoprotectants; Triterpenes
- Mechanism of Action Interferon beta stimulants; Interleukin 6 stimulants; Suppressor of cytokine signalling protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C